CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Up 3,601.8% in March

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 414,600 shares, a growth of 3,601.8% from the February 28th total of 11,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 4,146.0 days.

CanSino Biologics Stock Performance

CASBF stock remained flat at C$4.60 on Thursday. 45 shares of the company traded hands, compared to its average volume of 929. CanSino Biologics has a 1 year low of C$1.86 and a 1 year high of C$4.90. The company has a fifty day simple moving average of C$3.94 and a two-hundred day simple moving average of C$3.68.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.